Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2017 | 06-2017 | 03-2017 | 12-2016 | 09-2016 | |
| Sales | 23,545 | 20,073 | 24,915 | 25,722 | 25,118 |
| Cost of Goods | 15,318 | 12,072 | 15,978 | 14,348 | 12,480 |
| Gross Profit | 8,227 | 8,001 | 8,937 | 11,374 | 12,638 |
| Operating Expenses | 30,114 | 32,460 | 33,214 | 29,596 | 29,853 |
| Operating Income | -21,569 | -24,387 | -23,299 | -17,874 | -16,735 |
| Interest Expense | 633 | 826 | 838 | 839 | 821 |
| Other Income | 181 | -326 | 270 | -317 | 62 |
| Pre-tax Income | -22,021 | -25,539 | -23,867 | -19,030 | -17,494 |
| Net Income Continuous | -22,021 | -25,539 | -23,867 | -19,030 | -17,494 |
| Net Income | $-22,021 | $-25,539 | $-23,867 | $-19,030 | $-17,494 |
| EPS Basic Total Ops | -0.19 | -0.26 | -0.26 | -0.20 | -0.19 |
| EPS Basic Continuous Ops | -0.19 | -0.26 | -0.26 | -0.20 | -0.19 |
| EPS Diluted Total Ops | -0.19 | -0.26 | -0.26 | -0.20 | -0.19 |
| EPS Diluted Continuous Ops | -0.19 | -0.26 | -0.26 | -0.20 | -0.19 |
| EBITDA(a) | $-19,497 | $-22,065 | $-20,130 | $-16,509 | $-15,438 |